Tesamorelin 5mg Research Guide: Structure, Mechanism and Format Comparison

November 19, 2026
Tesamorelin 5mg research guide banner with the Ascend Peptides UK Tesamorelin 5mg vial

⚠️ Research Use Only. Tesamorelin 5mg is supplied strictly for in-vitro laboratory research. It is not intended for human consumption, therapeutic, diagnostic, or clinical use. All information below reflects peer-reviewed preclinical and scientific literature only. This content is not medical advice. Ascend Peptides UK accepts no liability for misuse of this product

If you are looking to buy Tesamorelin 5mg research peptide in the UK only for a laboratory programme, this guide covers everything you need to make an informed sourcing and experimental design decision. Tesamorelin 5mg is the entry-format version of one of the most scientifically distinctive GHRH research compounds available, a full-length GHRH analogue with N-terminal stabilisation that gives it a unique receptor engagement profile no other GHRH research peptide can replicate.


This guide is written for two audiences: UK-based laboratory researchers and research professionals evaluating tesamorelin 5mg for their first research programme or a pilot investigation, and scientifically engaged individuals who want to understand what this compound is, how it works, and why the 5mg format is the appropriate entry point for initial research work with this GHRH analogue.


All content below relates strictly to laboratory research and scientific investigation. Ascend Peptides UK supplies tesamorelin 5mg as a research peptide for laboratory use only, not for human consumption, veterinary, or clinical application of any kind.


What Is Tesamorelin? Structure and Scientific Identity

Tesamorelin is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), the endogenous hypothalamic peptide responsible for stimulating GH secretion from anterior pituitary somatotroph cells. For the complete structural and mechanistic background, see our full guide, What Is Tesamorelin?

Within the Ascend Peptides UK range, tesamorelin is distinguished from the other GHRH analogues by two structural features.


First, tesamorelin replicates the full 44-amino acid sequence of native GHRH, not a truncated version. Most other GHRH research peptides, including CJC-1295 without DAC and Sermorelin, are based on only the first 29 amino acids of the endogenous peptide. 

GHRH(1-29) already contains the sequence required for receptor activity, so whether the full-length sequence changes receptor interaction is an experimental question rather than an established advantage.


Second, tesamorelin carries a trans-3-hexenoic acid group covalently bonded to the N-terminal tyrosine residue. This modification makes it more resistant than native GHRH to cleavage by DPP-IV (dipeptidyl aminopeptidase IV), the plasma enzyme that rapidly inactivates native GHRH (Frohman et al., 1986). 

The result is a GHRH analogue designed to resist enzymatic degradation for longer than unmodified GHRH.


Tesamorelin 5mg Molecular Identity — Quick Reference

Identifier

Value

Scientific name

Tesamorelin (INN)

Type

full-length 44-amino-acid GHRH analogue

N-terminal modification

Trans-3-hexenoic acid group on N-terminal tyrosine

Molecular formula

C221H366N72O67S

Molecular weight

~5,135.94 Da

Receptor target

GHRH receptor (GHRHR) — Gs-coupled GPCR

Research category

Growth Hormone Research Peptide

Supplied form

Lyophilised powder — white to off-white

Format

5mg per vial (also available: 10mg)

Third-party testing

No 5mg certificate published yet; a Janoshik report is published for a tested 10mg sample

Buy tesamorelin 5mg research peptide UK — Ascend Peptides UK

Why Buy Tesamorelin 5mg Research Peptide? The Case for the Entry Format

Researchers looking to buy tesamorelin 5mg research peptide are typically at one of two stages in their programme: either beginning their first investigation with this GHRH analogue and wanting to validate methods before committing to larger quantities, or running smaller-scale studies where the compound volume requirements do not justify the 10mg format. Both are entirely valid scientific rationales for the 5mg format.


Consideration

Tesamorelin 5mg

Tesamorelin 10mg

Best suited for

Pilot studies, method development, preliminary investigations

Established programmes, multi-arm studies, high-throughput assays

Research stage

Early-stage or first-time tesamorelin research

Confirmed demand, ongoing programme

Dose-response capability

Limited concentration range

Full concentration gradient studies

Cost per milligram

Higher per mg — smaller quantity

Better value — larger quantity

Batch consistency

Single batch for pilot

Extended single-batch use

Aliquots possible

Fewer single-use aliquots

A greater number of aliquots

Ideal researcher type

First-time buyers, pilot-study users, small labs

Active programmes, institutions, CROs

Published testing

No certificate published yet

Janoshik report for a tested sample (results on the CoA page)


The most important practical advantage of starting with the tesamorelin 5mg research compound is risk management. When working with a GHRH analogue for the first time, establishing reconstitution protocols, validating assay conditions, and confirming that the compound behaves as expected in your specific cell model or experimental system, committing to the 10mg format before method validation is complete is unnecessary. 

The 5mg format provides sufficient material to run pilot assays and generate preliminary data, after which the 10mg format becomes the appropriate choice for the full programme.


For researchers who have already validated their tesamorelin protocols and are ready for a larger programme, our dedicated tesamorelin 10mg research peptide guide covers the advanced format in full, including why single-batch consistency matters for established programmes and how the 10mg format supports high-throughput assay designs.


How Tesamorelin 5mg Works in Laboratory Research Models

Understanding the mechanism of the tesamorelin 5mg research peptide is essential for designing rigorous experimental protocols and interpreting results correctly. Tesamorelin acts as an agonist at the GHRH receptor (GHRHR), a Gs-coupled G-protein-coupled receptor expressed predominantly on anterior pituitary somatotroph cells.


GHRHR Signalling Cascade

When tesamorelin binds to GHRHR, it initiates the following signalling sequence in laboratory research models:


  • GHRHR activation → Gs protein stimulation → adenylyl cyclase activation → intracellular cAMP elevation

  • Elevated cAMP → protein kinase A (PKA) activation → downstream transcription factor phosphorylation

  • PKA activation → increased GH mRNA transcription → pulsatile growth hormone secretion from somatotroph cells

  • GH secretion → hepatic IGF-1 production → downstream growth factor signalling cascade


Because the tesamorelin 5mg research compound uses the full 44-amino acid GHRH sequence, it can be compared directly with truncated GHRH(1-29) analogues in receptor structure-function studies. 

Any difference in receptor interaction between full-length and truncated analogues remains an experimental question.


Research Applications of Tesamorelin 5mg in Laboratory Settings

The tesamorelin 5mg research peptide is used across a range of scientific disciplines within the Growth Hormone Research Peptide category. The following research contexts represent the primary applications for which the compound has been studied in preclinical and clinical literature.


1. GH Axis Pilot Studies and Method Development

The 5mg format of tesamorelin research compound UK is particularly suited to pilot investigations of the GHRH-GH signalling axis. 

Researchers establishing assay conditions, validating antibody-based GH detection methods, or testing dose-response parameters before committing to larger experimental series use the 5mg format to generate preliminary data efficiently without overcommitting compound volume.


2. GHRH Receptor Biology Research

Because tesamorelin is a full-length GHRH analogue, it can be used in GHRH receptor studies comparing complete and truncated GHRH sequences. 

Examples include binding and downstream signalling assays. 

The 5mg format is appropriate for receptor binding assays and preliminary receptor characterisation work.


3. Metabolic Pathway Research

Tesamorelin peptide for research has been studied in the context of metabolic biology, particularly the role of the GH-IGF-1 axis in lipid metabolism and adipose tissue biology at the cellular level. 

Laboratory investigations using GHRH analogues to probe how upstream receptor activation influences downstream metabolic signalling pathways benefit from the 5mg format when the study design involves limited assay numbers or a specific cell line validation phase.


4. Comparative GHRH Analogue Studies

A productive line of laboratory research compares different GHRH analogues to understand how structural differences in truncated versus full-length sequence, different N-terminal modifications, and varying DPP-IV resistance profiles translate into measurable differences in receptor activation and GH secretion dynamics. 

Buying Tesamorelin 5mg research peptide alongside CJC-1295 without DAC or Sermorelin enables researchers to run direct comparative assays without requiring large volumes of either compound.


5. GH-IGF-1 Axis Upstream Research

Researchers studying the GH-IGF-1 signalling cascade, one of the most studied axes in endocrine and metabolic biology, use GHRH analogues as upstream stimulants in experimental designs that also examine downstream IGF-1 production and receptor effects.

For the downstream component of this research axis, our IGF-1 LR3 1mg research guide provides a detailed scientific overview of how IGF-1 LR3 functions as a growth factor research tool in the downstream signalling pathway, a compound frequently studied in conjunction with GHRH analogues in multi-pathway GH axis research programmes.


Tesamorelin 5mg vs Other GHRH Research Peptides

Researchers evaluating the tesamorelin 5mg research compound UK, alongside other GHRH analogues, need a clear picture of how these peptides differ scientifically. The following comparison covers the three GHRH research peptides available from Ascend Peptides UK.


Property

Tesamorelin 5mg/10mg

CJC-1295 Without DAC

Sermorelin

Amino acid length

44 (full-length GHRH)

29 (truncated GHRH)

29 (truncated GHRH)

N-terminal modification

Trans-3-hexenoic acid

4 amino acid substitutions

None

DPP-IV resistance

✓✓ High

✓✓ High

None (unmodified sequence)

Sequence coverage of native GHRH

Full length (44 AA)

First 29 AA

First 29 AA

Research distinction

Only full-length analogue in the Ascend range

Modified GRF(1-29); D-Ala2 for DPP-IV resistance

Closest to native GHRH

Format available

5mg + 10mg

10mg

2mg + 5mg


The most significant distinction for experimental design is the amino acid length. The tesamorelin 5mg research peptide uses all 44 amino acids of native GHRH, making it the only full-length GHRH analogue in the Ascend Peptides UK range. 

CJC-1295, without DAC and Sermorelin, uses only the first 29 amino acids. For a detailed comparison of CJC-1295 Without DAC, see our complete CJC-1295 Without DAC research guide.

Tesamorelin 5mg research peptide UK — Janoshik Certificate of Analysis third-party tested

Where to Buy Tesamorelin 5mg Research Peptide UK

When you buy Tesamorelin 5mg research peptide in the UK, the quality and analytical verification of the compound directly determine the reliability of your experimental data. 

Research programmes built on sub-standard compounds produce unreliable results, and with a full-length GHRH analogue carrying an N-terminal modification, verification of both the complete peptide sequence and the intact modification is recommended.


When evaluating a tesamorelin 5mg supplier UK, these are the quality standards every researcher should confirm before purchasing:


  • HPLC purity verification: a purity figure measured by High-Performance Liquid Chromatography on a batch-specific certificate (there is no single legal purity standard)

  • LC-MS identity confirmation: Molecular weight verified to match the expected full-length tesamorelin structure, including confirmation that the trans-3-hexenoic acid N-terminal modification is intact

  • Independent third-party testing: Certificate of Analysis from an external analytical laboratory, not in-house testing

  • Lyophilised format: Freeze-dried powder is the usual supplied format for a peptide of this size

  • Full batch traceability: Complete documentation for referencing in published research

  • Research-only labelling: No health, cosmetic, or clinical claims, clear research-use-only designation

  • UK-based supplier: Same working-day dispatch, no international transit delays or stability risks


Ascend Peptides UK supplies Tesamorelin 5mg research compound UK . A Janoshik certificate is published for a tested batch of Tesamorelin 10mg; no certificate is currently published for the 5mg format. We are a UK-based tesamorelin 5mg supplier serving independent researchers, private laboratories, and research institutions across the United Kingdom.


Buy Tesamorelin 5mg research peptide directly from Ascend Peptides UK, or explore our complete range of growth hormone research peptides and scientific compounds — all dispatched the same working day for orders placed before 3 pm, with free shipping on orders of £50 or more.


Storage and Reconstitution: Laboratory Reference

Storage requirements for Tesamorelin are currently being verified with the manufacturer. Ascend Peptides UK does not publish reconstitution, solvent or in-use instructions; these are decisions for your own validated laboratory protocol.

UK Regulatory Status and Research Compliance

Tesamorelin 5mg research peptide is classified as a research chemical in the United Kingdom. It is not a licensed general medicine, not approved for human consumption, and must not be used in any clinical, veterinary, or diagnostic context outside of properly regulated research frameworks.


Researchers should note that Tesamorelin has received regulatory approval in specific clinical formulations in other jurisdictions. The FDA approved Egrifta (tesamorelin for injection) in 2010 for a specific clinical indication; an EU marketing-authorisation application was withdrawn in 2012 without approval. 

This clinical history provides researchers with access to a published pharmacokinetic and safety dataset that many synthetic research peptides lack. However, this clinical history does not extend any licensed status to the 5mg lyophilised research format, which is supplied strictly for laboratory investigation.


For any in vivo animal research conducted in the UK, full compliance with the Animals (Scientific Procedures) Act 1986 (ASPA) is mandatory, requiring valid Home Office licences and full institutional ethical approval before any experimental work begins. All buyers are responsible for ensuring their acquisition and use of Tesamorelin 5mg research compound UK complies with applicable UK legislation and institutional ethics requirements.


Why UK Researchers Choose Ascend Peptides UK for Tesamorelin 5mg

Ascend Peptides UK is a dedicated research peptides company built to serve the needs of UK laboratories, research institutions, and scientifically engaged individuals. 

Our tesamorelin 5mg research peptide is one of the research compounds available with same working-day UK dispatch.


  • Published testing: A Janoshik certificate is published for a tested 10mg batch; none is published yet for the 5mg format

  • UK-based tesamorelin 5mg supplier UK: Same working-day dispatch for orders placed before 3 pm, no international transit delays

  • Both formats available: Tesamorelin 5mg for pilot work and method development; Tesamorelin 10mg for established programmes

  • Free shipping: On all orders of £50 or more across the United Kingdom

  • Complete Growth Hormone Peptide range: Tesamorelin, CJC-1295, Sermorelin, Ipamorelin, with Janoshik reports published for tested batches where available

  • Research-only supply: No health, cosmetic, or clinical claims on any product


Conclusion: Buy Tesamorelin 5mg Research Peptide UK

The tesamorelin 5mg research peptide is the full-length (44-amino-acid) GHRH analogue in the Ascend range, with an N-terminal trans-3-hexenoyl group that increases resistance to DPP-IV cleavage. 

For researchers beginning their first investigation with this compound, or running smaller-scale pilot studies that do not require the full 10mg volume, the 5mg format is the scientifically appropriate and cost-effective entry point.


For UK researchers and laboratories looking to buy tesamorelin 5mg research peptide from a reliable tesamorelin 5mg supplier UK, Ascend Peptides UK supplies this compound with same working-day UK dispatch on in-stock orders; its published Janoshik certificate covers a tested batch of the 10mg format.


Buy Tesamorelin 5mg research peptide today at Ascend Peptides UK.


Frequently Asked Questions 

Q: Where can I buy Tesamorelin 5mg research peptide in the UK?

A: Tesamorelin 5mg research peptide is available to buy directly from Ascend Peptides UK a UK-based tesamorelin 5mg supplier with same working-day dispatch for orders placed before 3 pm. A Janoshik certificate is published for a tested batch of the 10mg format. Free shipping on orders of £50 or more. All products are for laboratory research use only.

Q: What is the tesamorelin 5mg research peptide used for?

A: The tesamorelin 5mg research peptide is used in laboratory settings to study GHRH receptor biology, the hypothalamic-pituitary-somatotropic axis, GH secretion dynamics, metabolic pathway research via the GH-IGF-1 signalling cascade, and comparative GHRH analogue pharmacology. The 5mg format is particularly suited to pilot studies, method development, and preliminary investigations before committing to the larger 10mg format.

Q: What is the difference between tesamorelin 5mg and tesamorelin 10mg?

A: The compound is identical in both formats — the difference is quantity and the scale of the research programme each format supports. Tesamorelin 5mg is the appropriate choice for pilot studies, method development, first-time research with this compound, or smaller-scale assays. Tesamorelin 10mg is the appropriate choice for established programmes requiring multi-arm studies, full dose-response concentration ranges, or extended single-batch consistency. Both are available from Ascend Peptides UK; a Janoshik certificate is published for a tested 10mg batch.

Q: What makes Tesamorelin 5mg different from CJC-1295 and Sermorelin?

A: Tesamorelin is the only full-length GHRH analogue in the Ascend Peptides UK range — it replicates all 44 amino acids of native GHRH, modified with a trans-3-hexenoic acid group for N-terminal stability. CJC-1295, without DAC and Sermorelin, are both based on only the first 29 amino acids of GHRH. This makes it useful for structure-function studies comparing full-length and truncated GHRH analogues.

Q: Is Tesamorelin 5mg research peptide legal in the UK?

A: Yes. Tesamorelin 5mg research peptide is legal to purchase in the United Kingdom as a research chemical for legitimate scientific and laboratory use. It is not classified as a controlled substance under UK law. However, it is not approved for human consumption or general clinical use in the UK and must not be used outside of properly regulated research frameworks. All buyers are responsible for ensuring compliance with applicable regulations.

Q: What purity standard should Tesamorelin 5mg meet for research use?

A: There is no single legal purity standard for research-grade tesamorelin 5mg; look for an HPLC purity figure on a batch-specific certificate and compare it with your study requirements. Critically for a compound with an N-terminal modification, molecular identity — including confirmation that the trans-3-hexenoic acid group is intact — must be verified by LC-MS. A batch-specific Certificate of Analysis from an independent third-party laboratory is essential. Ascend Peptides UK publishes a Janoshik certificate for a tested 10mg batch.

Q: What is the tesamorelin 5mg price in the UK?

A: Tesamorelin 5mg research peptide is available from Ascend Peptides UK with competitive UK pricing. Free shipping applies to all orders of £50 or more, and bacteriostatic water is included free with orders of £75 or more. Visit the Ascend Peptides UK product page for current pricing and availability. All products are supplied for laboratory research use only.

Q: Can tesamorelin 5mg be used for GHRH receptor research?

A: Yes. The tesamorelin 5mg research compound is particularly well-suited to GHRH receptor biology studies because it is a full-length GHRH analogue that can be compared with truncated GHRH(1-29) analogues in studies of receptor structure-function relationships, binding and downstream signal transduction.


DISCLAIMER

All products supplied by Ascend Peptides UK are intended strictly for research purposes only. They are not intended for human consumption or for any therapeutic, diagnostic, or clinical use. None of the items offered are classified as medicinal products by the MHRA. It is the buyer’s responsibility to ensure all purchases comply with applicable laws and regulations. Ascend Peptides UK accepts no liability for misuse.